Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

JUBILANT GENERICS

  • FDA Approval
  • Dec. 09, 2024, 09:44 UTC
  • 32
  • 0 comments

FDA approve LURASIDONE HYDROCHLORIDE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Dec. 09, 2024, 05:32 UTC
  • 31
  • 0 comments

FDA approve CALCITONIN SALMON

Comment Full text

AVET PHARMACEUTICALS INC.

  • FDA Approval
  • Dec. 06, 2024, 20:27 UTC
  • 39
  • 0 comments

FDA approve ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE

Comment Full text

MYLAN PHARMACEUTICALS INC A VIATRIS CO

  • FDA Approval
  • Dec. 06, 2024, 19:59 UTC
  • 36
  • 0 comments

FDA approve PALIPERIDONE PALMITATE

Comment Full text

LUPIN LTD

  • FDA Approval
  • Dec. 06, 2024, 19:43 UTC
  • 34
  • 0 comments

FDA approve ABACAVIR;DOLUTEGRAVIR;LAMIVUDINE

Comment Full text

RENEW PHARMS

  • FDA Approval
  • Dec. 06, 2024, 14:27 UTC
  • 34
  • 0 comments

FDA approve INDOCYANINE GREEN

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Dec. 06, 2024, 09:49 UTC
  • 39
  • 0 comments

FDA approve EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Dec. 06, 2024, 09:49 UTC
  • 37
  • 0 comments

FDA approve FULVESTRANT

Comment Full text

CEDIPROF INC

  • FDA Approval
  • Dec. 05, 2024, 09:39 UTC
  • 28
  • 0 comments

FDA approve OSELTAMIVIR PHOSPHATE

Comment Full text

AMNEAL

  • FDA Approval
  • Dec. 05, 2024, 09:39 UTC
  • 33
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text
  • Previous
  • 185
  • 186
  • 187
  • 188
  • 189
  • Next

Search

News categories

  • Technical Exchange News(9878)
  • Event(407)
  • SEC News(167286)
  • FDA Approval(9344)
  • Company Report(721)
  • Business News(111138)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin